Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases

MS Meuleman, A Grunenwald, S Chauvet - Seminars in Immunology, 2022 - Elsevier
Abstract C3 glomerulopathy (C3G) is a rare and complex kidney disease that primarily
affects young adults. Renal outcomes remain poor in the absence of specific treatment. C3G …
被引用次数：8 相关文章

Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases.

MS Meuleman, A Grunenwald… - Seminars in Immunology, 2022 - europepmc.org
C3 glomerulopathy (C3G) is a rare and complex kidney disease that primarily affects young
adults. Renal outcomes remain poor in the absence of specific treatment. C3G is driven by …

Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases

MS Meuleman, A Grunenwald… - Seminars in …, 2022 - pubmed.ncbi.nlm.nih.gov
C3 glomerulopathy (C3G) is a rare and complex kidney disease that primarily affects young
adults. Renal outcomes remain poor in the absence of specific treatment. C3G is driven by …